Karuna Therapeutics (KRTX) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free KRTX Stock Alerts $329.83 0.00 (0.00%) (As of 04/1/2024) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Karuna Therapeutics Short Interest DataCurrent Short Volume1,970,000 sharesPrevious Short Volume2,110,000 sharesChange Vs. Previous Month-6.64%Dollar Volume Sold Short$618.52 millionShort Interest Ratio / Days to Cover2.3Last Record DateFebruary 29, 2024Outstanding Shares38,148,000 sharesPercentage of Shares Shorted5.16%Today's Trading Volume5 sharesAverage Trading Volume832,048 sharesToday's Volume Vs. Average0% Short Selling Karuna Therapeutics ? Sign up to receive the latest short interest report for Karuna Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKRTX Short Interest Over TimeKRTX Days to Cover Over TimeKRTX Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Karuna Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,970,000 shares $618.52 million -6.6%N/A2.3 $313.97 2/15/20242,110,000 shares $673.91 million +24.9%N/A2.5 $319.39 1/31/20241,690,000 shares $529.68 million +15.8%N/A2.1 $313.42 1/15/20241,460,000 shares $462.46 million -4.6%N/A2 $316.75 12/31/20231,530,000 shares $484.26 million -24.3%N/A2.5 $316.51 12/15/20232,020,000 shares $443.94 million -1.5%N/A4.7 $219.77 Get the Latest News and Ratings for KRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20232,050,000 shares $391.98 million +7.3%N/A7.7 $191.21 11/15/20231,910,000 shares $328.06 million +3.8%N/A8.1 $171.76 10/31/20231,840,000 shares $306.56 million +12.2%N/A7.7 $166.61 10/15/20231,640,000 shares $280.46 million -1.8%N/A6.5 $171.01 9/30/20231,670,000 shares $282.38 million +18.4%N/A6.6 $169.09 9/15/20231,410,000 shares $255.07 million +4.4%N/A5.3 $180.90 8/31/20231,350,000 shares $253.48 million -6.9%N/A3.9 $187.76 8/15/20231,450,000 shares $260.26 million +16.0%N/A4 $179.49 7/31/20231,250,000 shares $249.71 million -1.6%N/A3.3 $199.77 7/15/20231,270,000 shares $269.01 million -4.5%N/A3.3 $211.82 6/30/20231,330,000 shares $288.41 million -37.0%N/A3.3 $216.85 6/15/20232,110,000 shares $503.34 million -0.9%N/A5 $238.55 5/31/20232,130,000 shares $482.55 million +2.4%N/A5.2 $226.55 5/15/20232,080,000 shares $479.69 million -2.4%N/A5 $230.62 4/30/20232,130,000 shares $422.68 million +1.4%N/A5.1 $198.44 4/15/20232,100,000 shares $383.54 million -1.9%N/A5.2 $182.64 3/31/20232,140,000 shares $388.71 million +22.3%N/A5.5 $181.64 3/15/20231,750,000 shares $327.37 million +0.6%N/A4.8 $187.07 2/28/20231,740,000 shares $346.99 million +4.2%6.1%5.8 $199.42 2/15/20231,670,000 shares $324.23 million No Change5.9%5.8 $194.15 1/31/20231,670,000 shares $332.98 million -0.6%6.0%5.8 $199.39 1/15/20231,680,000 shares $337.26 million -2.9%6.0%5.7 $200.75 12/30/20221,730,000 shares $339.95 million +10.9%6.3%5.8 $196.50 12/15/20221,560,000 shares $312 million +6.1%5.6%4.8 $200.00 11/30/20221,470,000 shares $345.91 million -13.5%5.4%4.1 $235.31 11/15/20221,700,000 shares $392.31 million +4.9%6.2%4.8 $230.77 10/31/20221,620,000 shares $355.33 million No Change6.2%3.6 $219.34 10/15/20221,620,000 shares $333.56 million +14.9%6.4%3 $205.90 9/30/20221,410,000 shares $317.15 million -23.4%5.6%2.7 $224.93 9/15/20221,840,000 shares $449.07 million -1.1%7.3%3.5 $244.06 8/31/20221,860,000 shares $474.41 million -9.7%7.6%3.6 $255.06 8/15/20222,060,000 shares $563.84 million +36.4%8.4%4.2 $273.71 7/31/20221,510,000 shares $196.68 million +6.3%7.0%3.8 $130.25 7/15/20221,420,000 shares $191.97 million +5.2%6.6%4.7 $135.19The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! KRTX Short Interest - Frequently Asked Questions What is Karuna Therapeutics' current short interest? Short interest is the volume of Karuna Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 1,970,000 shares of KRTX short. Learn More on Karuna Therapeutics' current short interest. What is a good short interest ratio for Karuna Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRTX shares currently have a short interest ratio of 2.0. Learn More on Karuna Therapeutics's short interest ratio. Which institutional investors are shorting Karuna Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Karuna Therapeutics: Barclays PLC, Parallax Volatility Advisers L.P., Citadel Advisors LLC, PEAK6 Investments LLC, UBS Group AG, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Karuna Therapeutics' short interest increasing or decreasing? Karuna Therapeutics saw a decline in short interest in February. As of February 29th, there was short interest totaling 1,970,000 shares, a decline of 6.6% from the previous total of 2,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Karuna Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Karuna Therapeutics: BeiGene, Ltd. (1.81%), Dr. Reddy's Laboratories Limited (0.38%), Viatris Inc. (3.14%), Sarepta Therapeutics, Inc. (4.90%), United Therapeutics Co. (11.28%), Teva Pharmaceutical Industries Limited (1.03%), Catalent, Inc. (4.15%), Legend Biotech Co. (5.49%), Ascendis Pharma A/S (5.75%), BioMarin Pharmaceutical Inc. (1.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Karuna Therapeutics stock? Short selling KRTX is an investing strategy that aims to generate trading profit from Karuna Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Karuna Therapeutics? A short squeeze for Karuna Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRTX, which in turn drives the price of the stock up even further. How often is Karuna Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRTX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: BeiGene Short Interest Dr. Reddy's Laboratories Short Interest Viatris Short Interest Sarepta Therapeutics Short Interest United Therapeutics Short Interest Teva Pharmaceutical Industries Short Interest Catalent Short Interest Legend Biotech Short Interest Ascendis Pharma A/S Short Interest BioMarin Pharmaceutical Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRTX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Next Nvidia?InvestorPlaceHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing1970’s computer coder issues shocking A.I. warningTradeSmith